Study unveils link between oral bacteria and pancreatic cancer development in mice

Fred Pelzman is an associate professor of medicine at Weill Cornell, and has been a practicing internist for nearly 30 years. He is medical director

Mer­ck has once again failed to boost the ef­fects of its PD-1 block­buster Keytru­da by adding As­traZeneca’s PARP in­hibitor Lyn­parza. When giv­en as a main­te­nance

The FDA is alerting clinicians to a recall of Boston Scientific’s Accolade pacemakers, which have an increased risk of permanently entering “safety mode,” possibly requiring